Ivan Bièche

34.0k total citations · 1 hit paper
497 papers, 20.2k citations indexed

About

Ivan Bièche is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ivan Bièche has authored 497 papers receiving a total of 20.2k indexed citations (citations by other indexed papers that have themselves been cited), including 248 papers in Molecular Biology, 193 papers in Oncology and 136 papers in Cancer Research. Recurrent topics in Ivan Bièche's work include Cancer Genomics and Diagnostics (72 papers), Cancer-related Molecular Pathways (39 papers) and Estrogen and related hormone effects (37 papers). Ivan Bièche is often cited by papers focused on Cancer Genomics and Diagnostics (72 papers), Cancer-related Molecular Pathways (39 papers) and Estrogen and related hormone effects (37 papers). Ivan Bièche collaborates with scholars based in France, United States and Belgium. Ivan Bièche's co-authors include Rosette Lidereau, Michel Vidaud, Sophie Vacher, Ingrid Laurendeau, Dominique Vidaud, Sengül Tozlu, Éric Pasmant, Igor Girault, Martine Olivi and M.H. Champème and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

Ivan Bièche

477 papers receiving 19.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characterization of a Germ-Line Deletion, Including the Entire INK4/ARF Locus, in a Melanoma-Neural System Tumor Family: Identification of ANRIL , an Antisense Noncoding RNA Whose Expression Coclusters with ARF

2007 500 citations Éric Pasmant, Ingrid Laurendeau et al. Cancer Research profile →

Peers

Countries citing papers authored by Ivan Bièche

Since Specialization

Citations

This map shows the geographic impact of Ivan Bièche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Bièche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Bièche more than expected).

Fields of papers citing papers by Ivan Bièche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Bièche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Bièche. The network helps show where Ivan Bièche may publish in the future.

Co-authorship network of co-authors of Ivan Bièche

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Bièche. A scholar is included among the top collaborators of Ivan Bièche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Bièche. Ivan Bièche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CYYR1 promotes the degradation of the E3 ubiquitin ligase WWP1 and is associated with favorable prognosis in breast cancer 2024 ·Journal of Biological Chemistry ·(unknown), Mathieu Boissan, Ivan Bièche, (unknown), Florent Dingli, Damarys Loew, (unknown), Sabrina Colasse, Laurence Lévy, Céline Prunier	3
2	Association of ctDNA tumor fraction with survival in advanced non-small cell lung cancer (NSCLC) treated with maintenance durvalumab in the UNICANCER SAFIR02-Lung/IFCT1301 trial. 2023 ·Journal of Clinical Oncology ·Filippo Gustavo Dall’Olio, Damien Vasseur, Maryam Karimi, Stefan Michiels, Ludovic Lacroix, Pascale Tomasini, Judith Raimbourg, (unknown), Catherine Daniel, Henri Janicot, Anne Madroszyk, Clarisse Audigier-Valette, Ivan Bièche, Julien Mazières, (unknown), Marta Jimenez, Jean‐Charles Soria, Virginie Westeel, Fabrice Barlési, Benjamin Besse	0
3	Hereditary cancer predispositions: Comparison of multigene panel sequencing on fresh‐frozen breast/ovarian tumor versus blood 2023 ·Clinical Genetics ·(unknown), Virginie Moncoutier, (unknown), (unknown), (unknown), Mélanie Pagès, Julien Masliah‐Planchon, (unknown), Samia Melaabi, Céline Callens, Ivan Bièche, (unknown), Antoine De Pauw, Claire Saule, Emmanuelle Mouret‐Fourme, Marion Gauthier‐Villars, Bruno Buecher, Chrystelle Colas, Dominique Stoppa‐Lyonnet, Lisa Golmard	2
4	2022-RA-205-ESGO Circulating HPV DNA in cervical cancer: a marker for early detection of relapse 2022 ·International Journal of Gynecological Cancer ·Emmanuelle Jeannot, Aurélien Latouche, Claire Bonneau, Guillaume Bataillon, (unknown), Marina Popović, Anne de la Rochefordière, Fabrice Lécuru, Virginie Fourchotte, Ekaterina S. Jordanova, Heiko von der Leyen, Carine Tran‐Perennou, (unknown), Christophe Le Tourneau, Ivan Bièche, Roman Rouzier, Els M.J.J. Berns, Maud Kamal, Suzy Scholl	1
5	High Prevalence of a Hotspot of Noncoding Somatic Mutations in Intron 6 of GPR126 in Bladder Cancer 2018 ·Molecular Cancer Research ·Simon Garinet, G. Pignot, Sophie Vacher, C. Goux, Anne Schnitzler, Walid Chemlali, Nanor Sirab, Nicolas Barry Delongchamps, Marc Zerbib, Mathilde Sibony, Yves Allory, Diane Damotte, Ivan Bièche	18
6	Inactivation of the Kinase Domain of CDK10 Prevents Tumor Growth in a Preclinical Model of Colorectal Cancer, and Is Accompanied by Downregulation of Bcl-2 2017 ·Molecular Cancer Therapeutics ·Louis‐Bastien Weiswald, Mohammad R. Hasan, John C.T. Wong, (unknown), Mahbuba Rahman, Jianhua Ren, (unknown), Samuel Gusscott, Sophie Vacher, Andrew P. Weng, Hagen F. Kennecke, Ivan Bièche, David F. Schaeffer, Donald T. Yapp, Isabella T. Tai	17
7	Expression of ANRIL –Polycomb Complexes– CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene ( EZH2/CBX7 ) Signature with Independent Prognostic Value 2016 ·Molecular Cancer Research ·Didier Meseure, Sophie Vacher, Kinan Drak Alsibai, Nicolás André, Walid Chemlali, Martial Caly, Rosette Lidereau, Éric Pasmant, Céline Callens, Ivan Bièche	82
8	Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer 2016 ·Clinical Cancer Research ·(unknown), Ivan Bièche, Didier Meseure, Elisabetta Marangoni, Géraldine Buhagiar‐Labarchède, Nicolás André, Sophie Vacher, Rosine Onclercq-Delic, Vinodh N. Rajapakse, Sudhir Varma, William C. Reinhold, Yves Pommier, Mounira Amor-Guéret	26
9	Evaluating Patient-Derived Colorectal Cancer Xenografts as Preclinical Models by Comparison with Patient Clinical Data 2015 ·Cancer Research ·Manoel Nunes, Patricia Vrignaud, Sophie Vacher, Sophie Richon, Astrid Lièvre, Wulfran Cacheux, Louis‐Bastien Weiswald, Gérald Massonnet, Sophie Château‐Joubert, Nicolás André, Colette Dib, Weidong Zhang, James Watters, Donald A. Bergstrom, Sergio Roman‐Roman, Ivan Bièche, Virginie Dangles-Marie	56
10	Reduction of MicroRNA 122 Expression in IFNL3 CT/TT Carriers and during Progression of Fibrosis in Patients with Chronic Hepatitis C 2014 ·Journal of Virology ·Emilie Estrabaud, Martine Lapalus, Philippe Broët, (unknown), Simon De Muynck, Olivier Lada, Michelle Martinot-Peignoux, Ivan Bièche, Dominique Valla, Pierre Bédossa, Patrick Marcellin, Michel Vidaud, Tarik Asselah	29
11	Acquired Resistance to Endocrine Treatments Is Associated with Tumor-Specific Molecular Changes in Patient-Derived Luminal Breast Cancer Xenografts 2014 ·Clinical Cancer Research ·Paul Cottu, Ivan Bièche, Franck Assayag, Rania El Botty, Sophie Château‐Joubert, Aurélie Thuleau, (unknown), Benoît Albaud, Audrey Rapinat, David Gentien, Pierre de la Grange, Vonick Sibut, Sophie Vacher, (unknown), Jean‐Luc Servely, Jean‐Jacques Fontaine, Didier Decaudin, Jean‐Yves Pierga, Sergio Roman‐Roman, Elisabetta Marangoni	42
12	ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and Invasion 2012 ·Cancer Research ·Julie A. Vendrell, Aurélie Thollet, Nhan Trung Nguyen, Sandra E. Ghayad, Stéphanie Vinot, Ivan Bièche, (unknown), Véronique Josserand, Jean‐Luc Coll, Pierre Roux, Laura Corbo, Isabelle Treilleux, Ruth Rimokh, Pascale A. Cohen	95
13	Inhibiting Aurora Kinases Reduces Tumor Growth and Suppresses Tumor Recurrence after Chemotherapy in Patient-Derived Triple-Negative Breast Cancer Xenografts 2012 ·Molecular Cancer Therapeutics ·Angela Romanelli, (unknown), Franck Assayag, Sophie Château‐Joubert, Marie‐France Poupon, Jean‐Luc Servely, Jean‐Jacques Fontaine, Xiaohong Liu, E. T. C. Spooner, (unknown), Patricia de Crémoux, Ivan Bièche, Didier Decaudin, Elisabetta Marangoni	40
14	Genome-Wide DNA Methylation Profiling of CpG Islands in Breast Cancer Identifies Novel Genes Associated with Tumorigenicity 2011 ·Cancer Research ·Victoria Hill, Christopher J. Ricketts, Ivan Bièche, Sophie Vacher, Dean Gentle, Cheryl Lewis, Eamonn R. Maher, Farida Latif	126
15	Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome 2010 ·Blood ·Benjamin Terrier, Ivan Bièche, Thierry Maisonobe, Ingrid Laurendeau, Michèlle Rosenzwajg, Jean‐Emmanuel Kahn, Marie‐Claude Diemert, Lucile Musset, Michel Vidaud, D. Sène, N. Costedoat‐Chalumeau, (unknown), Zahir Amoura, David Klatzmann, P. Cacoub, David Saadoun	99
16	Epithelial-to-Mesenchymal Transition and Resistance to Ingenol 3-Angelate, a Novel Protein Kinase C Modulator, in Colon Cancer Cells 2009 ·Cancer Research ·Aïda Ghoul, Maria Serova, Lucile Astorgues‐Xerri, Ivan Bièche, Guilhem Bousquet, Mariana Varna, Michel Vidaud, (unknown), (unknown), Karim A. Benhadji, François Lokiec, Esteban Cvitkovic, Sandrine Faivre, Éric Raymond	44
17	A Six-Gene Signature Predicting Breast Cancer Lung Metastasis 2008 ·Cancer Research ·(unknown), Amanda Jackson, Akeila Bellahcène, Nadia Rucci, Soraya Sin, Berta Martín, Àngels Sierra, Alain Boudinet, Jean‐Marc Guinebretière, Enrico Ricevuto, Catherine Noguès, M Briffod, Ivan Bièche, P. Chérel, Teresa García, Vincent Castronovo, Anna Teti, Rosette Lidereau, Keltouma Driouch	121
18	Microarray-Based Identification of Tenascin C and Tenascin XB , Genes Possibly Involved in Tumorigenesis Associated with Neurofibromatosis Type 1 2007 ·Clinical Cancer Research ·Pascale Lévy, Hugues Ripoche, Ingrid Laurendeau, Vladimir Lazar, Nicolás Ortonne, Béatrice Parfait, Karen Leroy, Janine Wechsler, Isabelle Salmon, P. Wolkenstein, Philippe Dessen, Michel Vidaud, Dominique Vidaud, Ivan Bièche	43
19	Characterization of a Germ-Line Deletion, Including the Entire INK4/ARF Locus, in a Melanoma-Neural System Tumor Family: Identification of ANRIL , an Antisense Noncoding RNA Whose Expression Coclusters with ARF breakdown → 2007 ·Cancer Research ·Éric Pasmant, Ingrid Laurendeau, Delphine Héron, Michel Vidaud, Dominique Vidaud, Ivan Bièche	500
20	Molecular Profiling of Inflammatory Breast Cancer 2004 ·Clinical Cancer Research ·Ivan Bièche, Florence Lerebours, Sengül Tozlu, Marc Espié, M. Marty, Rosette Lidereau	188

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact